The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Social Anxiety Disorder: (532272011-001)
Abstract
CITATION: Seedat, S. 2013. Social anxiety disorder. South African Journal of Psychiatry, 19(3):192-196, doi:10.4102/sajpsychiatry.v19i3.953.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.629 · Cited by 2,695
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639
Psychometric properties of the Social Phobia Inventory (SPIN): New self-rating scale
Connor, K. M., Davidson, J. R. T., Churchill, L. E., Sherwood, A., Weisler, R. H., & Foa, E. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.4.379 · Cited by 1,624
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Comorbidity of Anxiety Disorders With Anorexia and Bulimia Nervosa
Kaye, W. H., Bulik, C. M., Thornton, L., Barbarich, N., Masters, K., & the Price Foundation Collaborative Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2215 · Cited by 1,162
Schneier (1992) · doi:10.1001/archpsyc.1992.01820040034004 · Cited by 1,142
Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey
Magee, W. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020077009 · Cited by 996
Psychometric properties of the Liebowitz Social Anxiety Scale
HEIMBERG, R. G., HORNER, K. J., JUSTER, H. R., SAFREN, S. A., BROWN, E. J., SCHNEIER, F. R., & LIEBOWITZ, M. R. (1999) · Psychological Medicine · doi:10.1017/s0033291798007879 · Cited by 968
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
WITTCHEN, H.-U., STEIN, M. B., & KESSLER, R. C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008174 · Cited by 745
Self-citationThe etiology of social phobia: empirical evidence and an initial model
Rapee, R. M., & Spence, S. H. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.06.004 · Cited by 693
Disability and Quality of Life in Social Phobia: Epidemiologic Findings
Stein, M. B., & Kean, Y. M. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1606 · Cited by 685
Grant, B. F., Hasin, D. S., Blanco, C., Stinson, F. S., Chou, S. P., Goldstein, R. B., Dawson, D. A., Smith, S., Saha, T. D., & Huang, B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1102 · Cited by 601
Increased Amygdala Activation to Angry and Contemptuous Faces in Generalized Social Phobia
Stein, M. B., Goldin, P. R., Sareen, J., Zorrilla, L. T. E., & Brown, G. G. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.11.1027 · Cited by 592
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441703 · Cited by 588
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., Juster, H. R., Campeas, R., Bruch, M. A., Cloitre, M., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1133 · Cited by 585
The ESEMeD/MHEDEA 2000 investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00329.x · Cited by 580
Antidepressants and the Risk of Suicidal Behaviors
Jick, H. (2004) · JAMA · doi:10.1001/jama.292.3.338 · Cited by 578
Simon, N. M., Otto, M. W., Wisniewski, S. R., Fossey, M., Sagduyu, K., Frank, E., Sachs, G. S., Nierenberg, A. A., Thase, M. E., Pollack, M. H., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2222 · Cited by 558
β-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction
Ko, D. T. (2002) · JAMA · doi:10.1001/jama.288.3.351 · Cited by 556
Phan, K. L., Fitzgerald, D. A., Nathan, P. J., & Tancer, M. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.012 · Cited by 539
Mini-SPIN: A brief screening assessment for generalized social anxiety disorder
Connor, K. M., Kobak, K. A., Churchill, L. E., Katzelnick, D., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1055 · Cited by 537
Furmark, T., Tillfors, M., Marteinsdottir, I., Fischer, H., Pissiota, A., Långström, B., & Fredrikson, M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.425 · Cited by 530
Inhibited and uninhibited infants “grown up”: adult amygdalar response to novelty
Schwartz, C. E., Wright, C. I., Shin, L. M., Kagan, J., & Rauch, S. L. (2003) · Science · doi:10.1126/science.1083703 · Cited by 528
Behavioral treatment of childhood social phobia.
Beidel, D. C., Turner, S. M., & Morris, T. L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.6.1072 · Cited by 518
Mennin, D. S., Fresco, D. M., Heimberg, R. G., Schneier, F. R., Davies, S. O., & Liebowitz, M. R. (2002) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(02)00134-2 · Cited by 506
Cognitive behavioral group treatment for social phobia: Comparison with a credible placebo control
Heimberg, R. G., Dodge, C. S., Hope, D. A., Kennedy, C. R., Zollo, L. J., & Becker, R. E. (1990) · Cognitive Therapy and Research · doi:10.1007/bf01173521 · Cited by 500
(1998) · PubMed · Cited by 460
Cognitive behavioral versus exposure only treatment for social phobia: A meta-analysis
Feske, U., & Chambless, D. L. (1995) · Behavior Therapy · doi:10.1016/s0005-7894(05)80040-1 · Cited by 447
Phenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison
Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R., et al. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.290 · Cited by 444
Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis.
Gould, R. A., Buckminster, S., Pollack, M. H., Otto, M. W., & Yap, L. (1997) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.1997.tb00123.x · Cited by 438
Child anxiety in primary care: Prevalent but untreated
Chavira, D. A., Stein, M. B., Bailey, K., & Stein, M. T. (2004) · Depression and Anxiety · doi:10.1002/da.20039 · Cited by 416
Self-citationFluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415
Cognitive-Behavioral and Pharmacological Treatments of Social Phobia: A Controlled Study
Gelernter, C. S. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810340070009 · Cited by 404
Social Phobia Subtypes in the National Comorbidity Survey
Kessler, R. C., Stein, M. B., & Berglund, P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.613 · Cited by 398
Self-citationPsychological and Pharmacological Treatments of Social Phobia: A Meta-Analysis
Fedoroff, I. C., & Taylor, S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00011 · Cited by 396
Treatment of Social Phobia With Gabapentin: A Placebo-Controlled Study
Pande, A. C., Davidson, J. R. T., Jefferson, J. W., Janney, C. A., Katzelnick, D. J., Weisler, R. H., Greist, J. H., & Sutherland, S. M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00010 · Cited by 395
Meta-analysis of cognitive-behavioral treatments for social phobia
Taylor, S. (1996) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(95)00058-5 · Cited by 374
Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
Stahl, S. M. (1996) · Medical Entomology and Zoology · Cited by 363
Neural correlates of genetically abnormal social cognition in Williams syndrome
Meyer-Lindenberg, A., Hariri, A. R., Munoz, K. E., Mervis, C. B., Mattay, V. S., Morris, C. A., & Berman, K. F. (2005) · Nature Neuroscience · doi:10.1038/nn1494 · Cited by 357
Stein, M. B., Liebowitz, M. R., Lydiard, R. B., Pitts, C. D., Bushnell, W., & Gergel, I. (1998) · JAMA · doi:10.1001/jama.280.8.708 · Cited by 348
Antidepressant Specificity in Atypical Depression
Liebowitz, M. R. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260037004 · Cited by 348
AUTISM: A Window Onto the Development of the Social and the Analytic Brain
Baron-Cohen, S., & Belmonte, M. K. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144137 · Cited by 341
Grant, B. F., Hasin, D. S., Stinson, F. S., Dawson, D. A., Patricia Chou, S., June Ruan, W., & Huang, B. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.05.004 · Cited by 335
Pharmacotherapy of Social Phobia: A Controlled Study with Moclobemide and Phenelzine
Versiani, M., Nardi, A. E., Mundim, F. D., Alves, A. B., Liebowitz, M. R., & Amrein, R. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.3.353 · Cited by 333
Low Dopamine D2 Receptor Binding Potential in Social Phobia
Schneier, F. R., Liebowitz, M. R., Abi-Dargham, A., Zea-Ponce, Y., Lin, S.-H., & Laruelle, M. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.457 · Cited by 325
Anxiety disorders in patients with Parkinson's disease
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.217 · Cited by 285
MANASSIS, K., MENDLOWITZ, S. L., SCAPILLATO, D., AVERY, D., FIKSENBAUM, L., FREIRE, M., MONGA, S., & OWENS, M. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200212000-00013 · Cited by 282
van Vliet, I. M., den Boer, J. A., & Westenberg, H. G. M. (1994) · Psychopharmacology · doi:10.1007/bf02244762 · Cited by 269
Social Anxiety in Outpatients With Schizophrenia: A Relevant Cause of Disability
Pallanti, S., Quercioli, L., & Hollander, E. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.53 · Cited by 266
Treatment of Social Phobia With Clonazepam and Placebo
DAVIDSON, J. R. T., POTTS, N., RICHICHI, E., KRISHNAN, R., FORD, S. M., SMITH, R., & WILSON, W. H. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199312000-00008 · Cited by 265
Impact of Generalized Social Anxiety Disorder in Managed Care
Katzelnick, D. J., Kobak, K. A., DeLeire, T., Henk, H. J., Greist, J. H., Davidson, J. R. T., Schneier, F. R., Stein, M. B., & Helstad, C. P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1999 · Cited by 262
Stein, M. B., Fyer, A. J., Davidson, J. R. T., Pollack, M. H., & Wiita, B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.756 · Cited by 262
Phenelzine v Imipramine in Atypical Depression: A Preliminary Report
Liebowitz, M. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790180039005 · Cited by 261
Stein, M. B. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020087010 · Cited by 259
Self-citationComorbid psychiatric disorders in depressed outpatients: Demographic and clinical features
Rush, A. J., Zimmerman, M., Wisniewski, S. R., Fava, M., Hollon, S. D., Warden, D., Biggs, M. M., Shores-Wilson, K., Shelton, R. C., Luther, J. F., et al. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.03.005 · Cited by 254
Baldwin, D., Bobes, J., Stein, D. J., Scharwächter, I., & Faure, M. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.2.120 · Cited by 251
Dopamine reuptake site densities in patients with social phobia
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.239 · Cited by 242
Prevention of childhood anxiety disorders
Donovan, C. L., & Spence, S. H. (2000) · Clinical Psychology Review · doi:10.1016/s0272-7358(99)00040-9 · Cited by 241
Wagner, K. D., Berard, R., Stein, M. B., Wetherhold, E., Carpenter, D. J., Perera, P., Gee, M., Davy, K., & Machin, A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1153 · Cited by 240
Self-citationSertraline for social phobia: a double-blind, placebo-controlled crossover study
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1368 · Cited by 238
Functional Impact and Health Utility of Anxiety Disorders in Primary Care Outpatients
Stein, M. B., Roy-Byrne, P. P., Craske, M. G., Bystritsky, A., Sullivan, G., Pyne, J. M., Katon, W., & Sherbourne, C. D. (2005) · Medical Care · doi:10.1097/01.mlr.0000185750.18119.fd · Cited by 233
Amir, N., Klumpp, H., Elias, J., Bedwell, J. S., Yanasak, N., & Miller, L. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.044 · Cited by 229
Brown, E. J., Heimberg, R. G., & Juster, H. R. (1995) · Behavior Therapy · doi:10.1016/s0005-7894(05)80095-4 · Cited by 229
Pande, A. C., Feltner, D. E., Jefferson, J. W., Davidson, J. R. T., Pollack, M., Stein, M. B., Lydiard, R. B., Futterer, R., Robinson, P., Slomkowski, M., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000117423.05703.e7 · Cited by 227
Self-citationA Direct-Interview Family Study of Generalized Social Phobia
Stein, M. B., Chartier, M. J., Hazen, A. L., Kozak, M. V., Tancer, M. E., Lander, S., Furer, P., Chubaty, D., & Walker, J. R. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.90 · Cited by 225
COMT Polymorphisms and Anxiety-Related Personality Traits
Stein, M. B., Fallin, M. D., Schork, N. J., & Gelernter, J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300787 · Cited by 224
Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study
Van Ameringen, M. A., Lane, R. M., Walker, J. R., Bowen, R. C., Chokka, P. R., Goldner, E. M., Johnston, D. G., Lavallee, Y.-J., Nandy, S., Pecknold, J. C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.275 · Cited by 223
Dismantling Cognitive-Behavioral Group Therapy for social phobia
Hope, D. A., Heimberg, R. G., & Bruch, M. A. (1995) · Behaviour Research and Therapy · doi:10.1016/0005-7967(95)00013-n · Cited by 222
Blomhoff, S., Haug, T. T., Hellström, K., Holme, I., Humble, M., Madsbu, H. P., & Wold, J. E. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.1.23 · Cited by 218
The Boundary of Social Phobia: Exploring the Threshold
Davidson, J. R. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950120047008 · Cited by 214
Furmark, T., Appel, L., Michelgård, Å., Wahlstedt, K., Åhs, F., Zancan, S., Jacobsson, E., Flyckt, K., Grohp, M., Bergström, M., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.029 · Cited by 206
Associations in the Course of Personality Disorders and Axis I Disorders Over Time.
Shea, M. T., Stout, R. L., Yen, S., Pagano, M. E., Skodol, A. E., Morey, L. C., Gunderson, J. G., McGlashan, T. H., Grilo, C. M., Sanislow, C. A., et al. (2004) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.113.4.499 · Cited by 203
Arbelle, S., Benjamin, J., Golin, M., Kremer, I., Belmaker, R. H., & Ebstein, R. P. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.671 · Cited by 202
The Brief Social Phobia Scale: a psychometric evaluation
DAVIDSON, J. R. T., MINER, C. M., DE VEAUGH-GEISS, J., TUPLER, L. A., COLKET, J. T., & POTTS, N. L. S. (1997) · Psychological Medicine · doi:10.1017/s0033291796004217 · Cited by 186
Battaglia, M., Ogliari, A., Zanoni, A., Citterio, A., Pozzoli, U., Giorda, R., Maffei, C., & Marino, C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.85 · Cited by 185
Effect of beta blockade and beta stimulation on stage fright.
Brantigan, C. O., Brantigan, T. A., & Joseph, N. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90592-7 · Cited by 178
Self-criticism and social phobia in the US national comorbidity survey
Cox, B. J., Fleet, C., & Stein, M. B. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2003.12.012 · Cited by 171
Blanco, C., Schneier, F. R., Schmidt, A., Blanco-Jerez, C.-R., Marshall, R. D., Sánchez-Lacay, A., & Liebowitz, M. R. (2003) · Depression and Anxiety · doi:10.1002/da.10096 · Cited by 170
Smoller, J. W., Yamaki, L. H., Fagerness, J. A., Biederman, J., Racette, S., Laird, N. M., Kagan, J., Snidman, N., Faraone, S. V., Hirshfeld-Becker, D., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.018 · Cited by 168
Social phobia in adults with stuttering
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.278 · Cited by 165
Lader, M., Stender, K., Bürger, V., & Nil, R. (2004) · Depression and Anxiety · doi:10.1002/da.20014 · Cited by 163
Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder
Liebowitz, M. R., Gelenberg, A. J., & Munjack, D. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.190 · Cited by 160
Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial
Haug, T. T., Blomhoff, S., Hellstrøm, K., Holme, I., Humble, M., Madsbu, H. P., & Wold, J. E. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.4.312 · Cited by 151
HERITABILITY OF SOCIAL ANXIETY-RELATED CONCERNS AND PERSONALITY CHARACTERISTICS: A TWIN STUDY
Stein, M. B., Jang, K. L., & Livesley, W. J. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200204000-00002 · Cited by 151
Noyes, R., Moroz, G., Davidson, J. R. T., Liebowitz, M. R., Davidson, A. B., Siegel, J., Bell, J., Cain, J. W., Curlik, S. M., Kent, T. A., et al. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00002 · Cited by 150
Massion, A. O., Dyck, I. R., Shea, M. T., Phillips, K. A., Warshaw, M. G., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.434 · Cited by 149
Placebo-controlled trial of moclobemide in social phobia
Schneier, F. R., Goetz, D. M., Campeas, R. B., Marshall, R. D., Fallon, B., & Liebowitz, M. R. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.172.1.70 · Cited by 147
Pollack, M. H., Simon, N. M., Zalta, A. K., Worthington, J. J., Hoge, E. A., Mick, E. O., Kinrys, G., & Oppenheimer, J. E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.005 · Cited by 146
EFFECT OF OXPRENOLOL ON STAGE-FRIGHT IN MUSICIANS
James, I. M., Griffith, D. N. W., Pearson, R. M., & Newbury, P. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90890-x · Cited by 144
Body dysmorphic disorder and social phobia: cross-sectional and prospective data
Coles, M. E., Phillips, K. A., Menard, W. E., Pagano, M. E., Fay, C., Weisberg, R. B., & Stout, R. L. (2005) · Depression and Anxiety · doi:10.1002/da.20132 · Cited by 133
Paroxetine in the Treatment of Generalized Social Phobia
Stein, M. B., Chartier, M., Hazen, A. L., Kroft, C. D. L., Chale, R. A., Cote, D. D., & Walker, J. R. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606000-00005 · Cited by 133
van der Linden, G. J., Stein, D. J., & van Balkom, A. J. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200008002-00004 · Cited by 130
Tranylcypromine in Social Phobia
Versiani, M., Mundim, F. D., Nardi, A. E., & Liebowitz, M. R. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198808000-00008 · Cited by 127
Escitalopram in the treatment of social anxiety disorder
Kasper, S. F., Stein, D. J., Loft, H., & Nil, R. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.3.222 · Cited by 127
Scrutinizing the relationship between shyness and social phobia
Chavira, D. A., Stein, M. B., & Malcarne, V. L. (2002) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(02)00124-x · Cited by 124
Efficacy of olanzapine in social anxiety disorder: a pilot study
Barnett, S. D., Kramer, M. L., Casat, C. D., Connor, K. M., & Davidson, J. R. T. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600412 · Cited by 123
Effectiveness of an empirically supported treatment for social phobia in the field
Lincoln, T. M., Rief, W., Hahlweg, K., Frank, M., von Witzleben, I., Schroeder, B., & Fiegenbaum, W. (2003) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(03)00038-x · Cited by 121
Liebowitz, M. R., Stein, M. B., Tancer, M. E., Carpenter, D. J., Oakes, R., & Pitts, C. D. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0113 · Cited by 117
Silverstone, P. H., & Salinas, E. O. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n07a04 · Cited by 116
Imipramine in the Treatment of Social Phobia
Simpson, H. B., Schneier, F. R., Campeas, R. B., Marshall, R. D., Fallon, B. A., Davies, S., Klein, D. F., & Liebowitz, M. R. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199804000-00005 · Cited by 116
van Vliet, I. M., den Boer, J. A., & Westenberg, H. G. M. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90032-4 · Cited by 116
Montgomery, S. A., Nil, R., Dürr-Pal, N., Loft, H., & Boulenger, J.-P. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1009 · Cited by 115
Open Trial of Interpersonal Psychotherapy for the Treatment of Social Phobia
Lipsitz, J. D., Markowitz, J. C., Cherry, S., & Fyer, A. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1814 · Cited by 115
Allgulander, C., Mangano, R. M., Zhang, J., Dahl, A. A., Lepola, U. M., Sjödin, I., & Emilien, G. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.602 · Cited by 114
Phobia: prevalence and risk factors
Boyd, J. H., Rae, D. S., Thompson, J. W., Burns, B. J., Bourdon, K., Locke, B. Z., & Regier, D. A. (1990) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00782887 · Cited by 112
Paroxetine in social anxiety disorder: a randomized placebo‐controlled study
Allgulander, C. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb10845.x · Cited by 112
Stein, M. B., Pollack, M. H., Bystritsky, A., Kelsey, J. E., & Mangano, R. M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1957-9 · Cited by 111
Fluoxetine in Social Phobia: A Double-Blind, Placebo-Controlled Pilot Study
Kobak, K. A., Greist, J. H., Jefferson, J. W., & Katzelnick, D. J. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00005 · Cited by 111
ISSAKIDIS, C., SANDERSON, K., CORRY, J., ANDREWS, G., & LAPSLEY, H. (2004) · Psychological Medicine · doi:10.1017/s003329170300881x · Cited by 110
Pharmacotherapy for social anxiety disorder
Stein, D. J., Ipser, J., & van Balkom, A. J. L. M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001206.pub2 · Cited by 110
Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders
Altamura, A. C., Pioli, R., Vitto, M. F., & Mannu, P. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199907000-00006 · Cited by 110
Fahlén, T., Nilsson, H., Borg, K., Humble, M. B., & Pauli, U. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09596.x · Cited by 109
A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder
Liebowitz, M. R., Mangano, R. M., Bradwejn, J., & Asnis, G. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0213 · Cited by 107
Fluoxetine for the Treatment of Social Phobia
BLACK, B., Uhde, T. W., & Tancer, M. E. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199208000-00022 · Cited by 106
Characteristics of social phobia among persons with essential tremor
Schneier, F. R., Barnes, L. F., Albert, S. M., & Louis, E. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0511 · Cited by 105
der Linden, G. V., van Heerden, B., Warwick, J., Wessels, C., van Kradenburg, J., Zungu‐Dirwayi, N., & Stein, D. J. (2000) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00109-8 · Cited by 102
The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.
Naranjo, C. A., & Knoke, D. M. (2001) · PubMed · Cited by 101
Moclobemide in social phobia: A double-blind, placebo-controlled clinical study
Katschnig, H. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900196 · Cited by 99
Rickels, K., Mangano, R. M., & Khan, A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000138764.31106.60 · Cited by 98
Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia
Ameringen, M. V., Mancini, C., & Wilson, C. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00030-4 · Cited by 97
Sertraline in Children and Adolescents With Social Anxiety Disorder: An Open Trial
Compton, S. N., GRANT, P. J., Chrisman, A. K., GAMMON, P. J., BROWN, V. L., & March, J. S. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200105000-00016 · Cited by 97
Stein, D. J., Stein, M. B., Pitts, C. D., Kumar, R., & Hunter, B. N. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0211 · Cited by 97
Efficacy of Sertraline in Severe Generalized Social Anxiety Disorder
Liebowitz, M. R., DeMartinis, N. A., Weihs, K. L., Londborg, P. D., Smith, W. T., Chung, H., Fayyad, R. S., & Clary, C. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0708 · Cited by 96
Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4???Tesla
Phan, K. L., Fitzgerald, D. A., Cortese, B. M., Seraji-Bozorgzad, N., Tancer, M. E., & Moore, G. J. (2005) · NeuroReport · doi:10.1097/00001756-200502080-00024 · Cited by 95
Are We Overpathologizing the Socially Anxious? Social Phobia from a Harmful Dysfunction Perspective
Wakefield, J. C., Horwitz, A. V., & Schmitz, M. F. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000604 · Cited by 94
Argyropoulos, S. V., Hood, S. D., Adrover, M., Bell, C., Rich, A. S., Nash, J. R., Rich, N. C., Witchel, H. J., & Nutt, D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.006 · Cited by 92
Stein, M. B., Sareen, J., Cissell, S. H., & Chao, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1725 · Cited by 92
Stage Fright in Musicians: A Model Illustrating the Effect of Beta Blockers
Neftel, K. A., Adler, R. H., Kappeli, L., Rossi, M., Dolder, M., Käser, H., Bruggesser, H., & Vorkauf, H. (1982) · Psychosomatic Medicine · doi:10.1097/00006842-198211000-00008 · Cited by 91
Lott, M., Greist, J. H., Jefferson, J. W., Kobak, K. A., Katzelnick, D. J., Katz, R. J., & Schaettle, S. C. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00003 · Cited by 91
The Effect of Beta Adrenergic Blocking Drugs on Speakers' Performance and Memory
Hartley, L. R., Ungapen, S., Davie, I., & Spencer, D. J. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.142.5.512 · Cited by 91
Social anxiety disorder: an unrecognized problem in primary care.
Katzelnick, D. J., & Greist, J. H. (2001) · PubMed · Cited by 89
Paroxetine for social anxiety and alcohol use in dual-diagnosed patients
Randall, C. L., Johnson, M., Thevos, A. K., Sonne, S. C., Thomas, S. E., Willard, S. L., Brady, K. T., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1077 · Cited by 89
Gelernter, J. E., Page, G. P., Stein, M. B., & Woods, S. W. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.59 · Cited by 89
Pharmacotherapy of social anxiety disorder
Blanco, C., Antia, S. X., & Liebowitz, M. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01294-x · Cited by 88
Muehlbacher, M., Nickel, M. K., Nickel, C., Kettler, C., Lahmann, C., Gil, F. P., Leiberich, P. K., Rother, N., Bachler, E., Fartacek, R. R., et al. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000186871.04984.8d · Cited by 88
Chartier, M., Hazen, A. L., & Stein, M. B. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:3<126::aid-da5>3.0.co;2-9 · Cited by 87
Treatment of anxiety disorders to remission.
Ballenger, J. C. (2001) · PubMed · Cited by 86
Kelsey, J. E. (1995) · PubMed · Cited by 85
Walker, J. R., Van Ameringen, M. A., Swinson, R., Bowen, R. C., Chokka, P. R., Goldner, E., Johnston, D. C., Lavallie, Y.-J., Nandy, S., Pecknold, J. C., et al. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00009 · Cited by 84
Batten, S. V., Aslan, M., Maciejewski, P. K., & Mazure, C. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0216 · Cited by 84
Degonda, M., & Angst, J. (1993) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191571 · Cited by 82
Hepatic Adverse Reactions Associated with Nefazodone
Stewart, D. E. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700409 · Cited by 80
Bouwer, C., & Stein, D. J. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00182-1 · Cited by 80
Stein, M. B., Chartier, M., Lizak, M. V., & Jang, K. L. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20010108)105:1<79::aid-ajmg1067>3.0.co;2-f · Cited by 74
Stein, D. J., Cameron, A., Amrein, R., & Montgomery, S. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200207000-00002 · Cited by 74
Social anxiety disorder: comorbidity and its implications.
Lydiard, R. B. (2001) · PubMed · Cited by 74
Ameringen, M. V., Mancini, C., & Oakman, J. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0205 · Cited by 73
Westenberg, H. G. M., Stein, D. J., Yang, H., Li, D., & Barbato, L. M. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104906.75206.8b · Cited by 73
Childhood Social Anxiety Disorder: From Understanding to Treatment
Chavira, D. A., & Stein, M. B. (2005) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.05.003 · Cited by 71
Self-citationA polymorphism of the β1-adrenergic receptor is associated with low extraversion
Stein, M. B., Schork, N. J., & Gelernter, J. E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.020 · Cited by 70
Hyperhidrosis in social anxiety disorder
Davidson, J. R. T., Foa, E. B., Connor, K. M., & Churchill, L. E. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00297-x · Cited by 69
Schneier, F. R., Chin, S. J., Hollander, E., & Liebowitz, M. R. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199202000-00018 · Cited by 68
Childhood shyness and maternal social phobia: A community study
Cooper, P., & Eke, M. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.174.5.439 · Cited by 60
Schneier, F. R., Saoud, J. B., Campeas, R. B., Fallon, B. A., Hollander, E., Coplan, J. D., & Liebowitz, M. R. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199308000-00004 · Cited by 59
(2001) · PubMed · Cited by 58
Lenox‐Smith, A., & Reynolds, A. (2003) · Europe PMC (PubMed Central) · Cited by 58
Yeragani, V. K., Nadella, R., Hinze, B., Yeragani, S., & Jampala, V. C. (2000) · Depression and Anxiety · doi:10.1002/1520-6394(2000)12:2<111::aid-da9>3.0.co;2-3 · Cited by 57
Citalopram treatment of social anxiety disorder with comorbid major depression
Schneier, F. R., Blanco, C., Campeas, R. B., Lewis‐Fernández, R., Lin, S., Marshall, R. D., Schmidt, A. B., Sanchez-Lacay, J. A., Simpson, H. B., & Liebowitz, M. R. (2003) · Depression and Anxiety · doi:10.1002/da.10112 · Cited by 56
James, I. M., Burgoyne, W., & Savage, I. (1983) · Journal of the Royal Society of Medicine · doi:10.1177/014107688307600308 · Cited by 54
A pilot study of buspirone in the treatment of social phobia
Munjack, D. J., Bruns, J. R., Baltazar, P. L., Brown, R. A., Leonard, M., Nagy, R., Koek, R. J., Crocker, B., & Schafer, S. (1991) · Journal of Anxiety Disorders · doi:10.1016/0887-6185(91)90019-p · Cited by 53
Chavira, D. A., & Stein, M. B. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460252943560 · Cited by 52
Effect of β Blockade on Singing Performance
Gates, G. A., Johnson, L., Saegert, J., Shepherd, A., Wilson, N., & Erwin, M. (1985) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348948509400609 · Cited by 51
Cognitive-behavioral treatment of social phobia: New advances
Huppert, J. D., Roth, D. A., & Foa, E. B. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0058-5 · Cited by 50
Pallanti, S., Quercioli, L., Rossi, A., & Pazzagli, A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1203 · Cited by 50
Stein, D. J., Kasper, S. F., Andersen, E. W., Nil, R., & LADER, M. H. (2004) · Depression and Anxiety · doi:10.1002/da.20043 · Cited by 49
Stein, D. J., Westenberg, H. G. M., Yang, H., Li, D., & Barbato, L. M. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570300364x · Cited by 49
Stein, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90604-2 · Cited by 48
Taijin kyofusho: a form of social anxiety disorder that responds to serotonin reuptake inhibitors?
Matsunaga, H., Kiriike, N., Matsui, T., Iwasaki, Y., & Stein, D. J. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002474 · Cited by 48
Treatment of Social Phobia with Bupropion
Emmanuel, N. P., Lydiard, R. B., & Ballenger, J. C. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199108000-00023 · Cited by 42
Is ?shy bladder syndrome? a subtype of social anxiety disorder? A survey of people with paruresis
Vythilingum, B., Stein, D. J., & Soifer, S. D. (2002) · Depression and Anxiety · doi:10.1002/da.10061 · Cited by 42
Non‐pharmacologic treatments for social anxiety disorder
Zaider, T., & Heimberg, R. G. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s417.8.x · Cited by 40
BETA-BLOCKING AGENTS IN THE TREATMENT OF CATECHOLAMINE-INDUCED SYMPTOMS IN MUSICIANS
Lidén, S., & Gottfries, C. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92060-1 · Cited by 40
The effect of acute beta‐adrenoceptor blockade on examination performance.
Drew, P., Barnes, J., & Evans, S. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02714.x · Cited by 40
Stein, D., Stein, M., Goodwin, W., Kumar, R., & Hunter, B. (2001) · Psychopharmacology · doi:10.1007/s002130100880 · Cited by 39
Self-citationAn Open Clinical Trial of Reboxetine in the Treatment of Social Phobia
Atmaca, M., Tezcan, E., & Kuloğlu, M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000085419.74359.a4 · Cited by 37
Stein, D. J. (1991) · Comprehensive Psychiatry · doi:10.1016/0010-440x(91)90017-7 · Cited by 36
Psychiatric correlates of childhood shyness in a nationally representative sample
Cox, B. J., MacPherson, P. S. R., & Enns, M. W. (2004) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.07.006 · Cited by 36
Brief Measures to Screen for Social Phobia in Primary Care Pediatrics
Bailey, K. A., Chavira, D. A., Stein, M. T., & Stein, M. B. (2005) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsj044 · Cited by 34
A Review of 19 Double-Blind Placebo-Controlled Studies in Social Anxiety Disorder (Social Phobia)
Versiani, M. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150563 · Cited by 31
A large open multicentre trial of clomipramine (Anafranil) in the management of phobic disorders.
Beaumont, G. (1977) · PubMed · Cited by 29
Phenomenology and epidemiology of social phobia
Stein, M. B. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199710006-00005 · Cited by 24
Phenelzine efficacy in refractory social anxiety disorder: A case series
Aarre, T. F. (2003) · Nordic Journal of Psychiatry · doi:10.1080/08039480310002110 · Cited by 22
Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings
Atmaca, M., Kuloğlu, M., Tezcan, E., & Ünal, A. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.436 · Cited by 20
Social anxiety disorder: designing a pharmacologic treatment strategy.
Pollack, M. H. (1999) · PubMed · Cited by 18
Effect of beta-blockade during bowling competitions.
Siitonen, L., & Jänne, J. (1976) · PubMed · Cited by 18
State-dependent effects of atypical benzodiazepine-receptor agonists
Jackson, A. E. (1995) · Psychopharmacology · doi:10.1007/bf02245855 · Cited by 17
Keith, J. R., Pitts, R. C., Pezzuti, T., et al. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200302000-00007 · Cited by 16
Feltner, D. E., Pollack, M. H., Davidson, J. R. T., Stein, M. B., Futterer, R., Jefferson, J. W., Lydiard, R. B., DuBoff, E., Robinson, P., Phelps, M. C., et al. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)80439-3 · Cited by 12
Algorithm for the pharmacotherapy of anxiety disorders
Stein, D. J. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0057-6 · Cited by 7
Social anxiety in primary care: hidden in plain view?
Roy‐Byrne, P., & Stein, M. B. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.03.001 · Cited by 6
Treating social anxiety disorder with venlafaxine extended release
Mangano, R. M. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)80572-7 · Cited by 4
Efficacy of Paroxetine for Relapse Prevention in Social Anxiety Disorder: A 24-Week Study
Stein, D. J., Versiani, M., Hair, T., & Kumar, R. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1111
Lorberbaum (1999) · doi:10.1002/(sici)1520-6394(1999)10:3
Cited by
Public health significance of neuroticism
Lahey, B. B. (2009) · American Psychologist · doi:10.1037/a0015309 · Cited by 1,901
The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology
Martin, E. I., Ressler, K. J., Binder, E., & Nemeroff, C. B. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.05.004 · Cited by 557
Social anxiety disorder: questions and answers for the DSM-V
Bögels, S. M., Alden, L., Beidel, D. C., Clark, L. A., Pine, D. S., Stein, M. B., & Voncken, M. (2010) · Depression and Anxiety · doi:10.1002/da.20670 · Cited by 526
Self-citationFelix-Ortiz, A. C., Burgos-Robles, A., Bhagat, N. D., Leppla, C. A., & Tye, K. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.041 · Cited by 413
Andersson, G., Carlbring, P., Holmström, A., Sparthan, E., Furmark, T., Nilsson-Ihrfelt, E., Buhrman, M., & Ekselius, L. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.677 · Cited by 382
Metadata
- Venue
- PsycEXTRA Dataset
- Published
- 2008
- Volume
- 4
- Issue
- 11
- Pages
- 17-17
- OpenAlex
- W2422017425
- Cited by
- 258
- References
- 198
- Type
- dataset
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.